文献速递关节外科骨质疏松与代谢性骨病

体重指数≥50 kg/m²患者初次全膝关节置换术:长期随访队列研究

Primary Total Knee Arthroplasty in Patients with BMI of ≥50 kg/m 2: A Cohort Study with Long-Term Follow-up.
PubMed 文献 · J Bone Joint Surg Am · 2025-05-23

该回顾性队列研究在学术中心纳入10389例因退行性关节炎行初次全膝关节置换术的患者,比较BMI≥50 kg/m²组(627例)与其他体重组的结局,平均随访8.6年。以超重患者(BMI 25至29.99 kg/m²)为参照,BMI≥50 kg/m²组术后第一年翻修调整HR为3.7(95%CI=1.9至7.2),一年后HR为1.2(95%CI=0.7至2.4)。BMI 35至39.99 kg/m²组与40至49.99 kg/m²组之间几无差异;BMI≥50 kg/m²组术前功能更差(OKS中位数15 vs 超重组23),但报告获益且满意度高。

要点

  • BMI≥50 kg/m²患者术后第一年翻修风险升高,调整HR为3.7(95%CI=1.9至7.2),一年后未达统计学显著(HR=1.2,95%CI=0.7至2.4)。
  • BMI 35至39.99 kg/m²组与40至49.99 kg/m²组之间翻修风险几无差异。
  • BMI≥50 kg/m²组术前OKS中位数15,低于超重组的23,但报告获益且满意度高。

核心结论

  • 研究证实BMI≥50 kg/m²患者全膝关节置换术后第一年失败风险增加,但未发现BMI 40至49.99 kg/m²组较35至39.99 kg/m²组结局更差。
  • BMI≥50 kg/m²组翻修风险增加仅见于术后第一年,之后趋于平稳。
  • 尽管功能更差且失败率更高,BMI≥50 kg/m²患者报告从全膝关节置换术中获益且满意度高。

研究设计与样本

  • 回顾性队列研究,纳入学术中心因退行性关节炎行初次全膝关节置换术的患者10389例(女6821例、男4070例、性别未知38例),平均随访8.6年。
  • 比较BMI≥50 kg/m²组(627例)与其他体重组的结局,采用Cox比例风险模型估计BMI与翻修风险的关联,以超重患者(BMI 25至29.99 kg/m²)为参照组并调整年龄和性别。
  • 术前及术后1年、5年、10年比较患者满意度、视觉模拟量表(VAS)疼痛评分和牛津膝关节评分(OKS)。

主要发现

  • 术后第一年,以超重患者为参照,BMI≥50 kg/m²组翻修全膝关节置换术的调整HR为3.7(95%CI=1.9至7.2)。
  • BMI 35至39.99 kg/m²组与BMI 40至49.99 kg/m²组之间几无差异。
  • 术后第一年之后,BMI≥50 kg/m²组翻修全膝关节置换术的HR为1.2(95%CI=0.7至2.4)。
  • BMI≥50 kg/m²组术前膝关节功能更差,OKS中位数为15,超重组为23。
  • 肥胖患者BMI每增加1个单位,术后1年OKS改善额外增加0.07分(95%CI=0.04至0.10)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The obesity epidemic has given rise to an orthopaedic patient subgroup with a body mass index (BMI) of ≥50 kg/m 2 . Without sound evidential guidance, arthroplasty surgeons and anesthesiologists do not know whether they can push the limits of the surgical feasibility of total knee arthroplasty (TKA) without risks of harm. METHODS: In a retrospective cohort study of patients who had undergone primary TKA for degenerative arthritis at our academic center (n = 10,389; 6,821 women, 4,070 men, and 38 unknown), we compared the outcomes between patients with a BMI of ≥50 kg/m 2 (n = 627) and patients in other weight classes. The average patient follow-up was 8.6 years. We used Cox proportional hazards models to estimate the association between BMI and revision risk, using overweight patients (BMI = 25 to 29.99 kg/m 2 ) as the reference group while adjusting for patient age and sex. Patient satisfaction, pain scores on a visual analogue scale (VAS), and the Oxford Knee Score (OKS) were compared among groups preoperatively and at 1, 5, and 10 years postoperatively. RESULTS: In the first year after surgery, the adjusted hazard ratio (HR) for revision TKA for patients with a BMI of ≥50 kg/m 2 was 3.7 (95% confidence interval [CI] = 1.9 to 7.2), with overweight patients as the reference. There was virtually no difference between patients with a BMI of 35 to 39.99 kg/m 2 and those with a BMI of 40 to 49.99 kg/m 2 . After the first year, the HR was 1.2 (95% CI = 0.7 to 2.4) for revision TKA for patients with a BMI of ≥50 kg/m 2 . Those patients reported worse preoperative function of the knee, with a median OKS of 15 versus 23 for overweight patients. For obese patients, each additional unit of BMI corresponded with an additional OKS improvement of 0.07 point (95% CI = 0.04 to 0.10) at 1 year. CONCLUSIONS: Our study confirms the increased risk of failure of TKA in patients with a BMI of ≥50 kg/m 2 in the first year after surgery, but we found no evidence of worse outcomes in the 40 to 49.99 kg/m 2 group compared with the 35 to 39.99 kg/m 2 group. The increase in the revision risk in the ≥50 kg/m 2 group was found only in the first postoperative year and plateaued afterwards. Despite worse function and higher failure rates, patients with a BMI of ≥50 kg/m 2 reported benefits and high satisfaction with TKA. LEVEL OF EVIDENCE: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Righolt CH, Armstrong ML, Turgeon TR, et al. Primary Total Knee Arthroplasty in Patients with BMI of ≥50 kg/m 2: A Cohort Study with Long-Term Follow-up. J Bone Joint Surg Am. 2025. PMID: 40408452. doi:10.2106/JBJS.24.01060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。